Erratum: Polydatin inhibits hepatocellular carcinoma via the AKT/STAT3-FOXO1 signaling pathway.

Jian Jiang,Tianxiu Dong,Yu Zhang,Jiuwei Zhang,Yaodong Chen,Xiuhua Yang,Pengfei Liu,Tingting An,Minlu Yue

doi:10.3892/ol.2019.10856

Abstract

[This corrects the article DOI: 10.3892/ol.2019.10123.].

Highlights

To the publication of this article, the authors have realized that Fig. 3 contained a duplicated panel: In Fig. 3A, the data correctly shown for the 0 h, ‘Control’ panel was inadvertently copied across to the 0 h, ‘100 μmol/l’ panel
Note that this error did not affect the overall conclusions reported in the paper
The authors apologize to the Editor of Oncology Letters and to readership for any inconvenience caused

Summary

Introduction

To the publication of this article, the authors have realized that Fig. 3 contained a duplicated panel: In Fig. 3A, the data correctly shown for the 0 h, ‘Control’ panel was inadvertently copied across to the 0 h, ‘100 μmol/l’ panel.

Results

Conclusion